Completed

Reproducibility of Multi-Nuclear Data and Optical Spectroscopy for ATP Characterization in Human Applications

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This observational study aims to measure the rate of phosphocreatine decay and oxygen uptake in your body during muscle contractions, using multi-nuclear data and optical spectroscopy, to understand ATP (energy) characterization in human applications.

What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

From 18 to 89 Years
+20 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: March 2013
See protocol details

Summary

Principal SponsorAdventHealth Translational Research Institute
Last updated: April 17, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: March 1, 2013

Actual date on which the first participant was enrolled.

Primary Study Objective: To evaluate the reproducibility of acquiring multi-nuclear data on a new 3T Philips Magnet in conjunction with Optical Spectroscopy.

NCT01827527
Principal SponsorAdventHealth Translational Research Institute
Last updated: April 17, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

31 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 89 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

8 inclusion criteria required to participate
Able to follow a 3-step command
Able to remain in magnetic resonance (MR) scanner for up to 2 hours
Able to travel to hospital for study visits
Able to walk 50 yards without stopping
Show More Criteria
12 exclusion criteria prevent from participating
Are pregnant or plan on becoming pregnant in the next 8 weeks
Are unwilling or unable to complete the imaging procedures for the duration of the magnetic resonance imaging (MRI) scan due to claustrophobia or other reason
Diagnosed peripheral arterial or vascular disease
Family history of primary DVT or PE
Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Translational Research Institute for Metabolism and Diabetes

Orlando, United StatesOpen Translational Research Institute for Metabolism and Diabetes in Google Maps
CompletedOne Study Center